The coronavirus (COVID-19) pandemic has pushed the pause button on talc trials across the country, but that doesn’t mean attorneys have relaxed their preparations.
“I was looking at three trials back-to-back-to-back,” Beasley Allen Law Firm principal Ted Meadows told Law.com. “My hope is these judges will reset these cases for trial as soon as possible, and so we’ll continue to get ready for those trials in hopes that the judges are thinking the same things we are.”
Meadows represents plaintiffs in three talc trials — a retrial of a talc case in Georgia federal court that ended in a mistrial last year, was slated for April 6; Illinois’ first first talc case involving ovarian cancer claims, which was originally scheduled for May 4; and a case in Philadelphia’s Court of Common Pleas, scheduled for June 15 and not currently delayed.
Most of the talc cases name Defendant Johnson & Johnson, and allege that the consumer health care giant knew for decades that its talc could contain asbestos, a known carcinogen, and other impurities that could harm consumers. Plaintiffs claim that using Johnson & Johnson’s talcum powder products, including its iconic Johnson’s baby powder and Shower to Shower body powder, on their genitals for personal hygiene caused them to develop ovarian cancer.
Beasley Allen has been privileged to represent thousands of women who developed ovarian cancer after using Johnson & Johnson talcum powder on their genitals for feminine hygiene. The firm continues to investigate these cases. For information, contact Ted Meadows, who heads up Beasley Allen’s Talc Litigation team, and Leigh O’Dell, who serves as co-lead counsel in the talc federal multidistrict litigation.